Mindfulness Based Stress Reduction in People with Parkinson’s Disease and their Carepartners
Objective: To assess the feasibility and impact of mindfulness based stress reduction (MBSR) on people with Parkinson’s disease (PD) and their carepartners. Background: Non-motor symptoms…Gastrointestinal symptoms as a risk factor for the appearance of motor fluctuations in patients with advanced Parkinson disease
Objective: Gastrointestinal alterations in patients with Parkinson`s Disease (EP) provoke alterations in the absorption of levodopa that facilitates the development of motor fluctuations. Study the…Four square step test in patients with early de novo Parkinson’s disease
Objective: The Four Square Step Test (FSST) is brief and easy tool to assess dynamic balance to step over hindrance. Originally developed for older adults,…Unilateral Leg Freezing in Moyamoya Syndrome
Objective: To report unilateral leg freezing in a patient with moyamoya syndrome. Background: Angiographic moyamoya is characterized by severe bilateral distal carotid stenosis with “puff-of-smoke”…Electroconvulsive Therapy (ECT): An Effective Option for the Treatment of Medication-Resistant Psychiatric Symptoms in Huntington’s Disease: A Case Series and Review of the Literature
Objective: Through a single site case series, we investigate the use and effectiveness of electroconvulsive therapy (ECT) for the treatment of refractory psychiatric symptoms in…Insomnia as clinical onset symptom in Juvenile Huntington’s Disease: Evaluation of a Family
Objective: The aim of this study to emphasize that three juvenile form of HD cases who have insomnia as clinical onset symptoms. Background: Huntington’s Disease…A global survey on speech language therapists’ awareness to Huntington’s disease
Objective: To investigate the awareness and knowledge of speech and language therapists (SLTs) on Huntington’s disease (HD) worldwide, and to explore the clinical practice and…Novel exploratory outcome assessments in GENERATION HD1
Objective: To improve collection of outcomes meaningful to patients with Huntington’s disease (HD) and their families, through the development of novel assessments of daily functional…A Multiple Ascending-Dose Study of LY3154207, A Dopamine D1 Receptor Positive Allosteric Modulator (D1PAM)
Objective: Evaluate the safety, tolerability, and pharmacokinetics (PK) of multiple oral LY3154207 (LY) doses in healthy subjects (HS) and persons with Parkinson’s disease (PWPD). Background:…Analysis of Levodopa Content in Commercial Formulations of Mucuna pruriens Seeds Used in Integrative Treatment of Parkinson’s Disease
Objective: Objective: Formulations of Mucuna pruriens (MP) seed products are readily available through the internet and health food stores, and are used by some Parkinson's…
- « Previous Page
- 1
- …
- 202
- 203
- 204
- 205
- 206
- …
- 217
- Next Page »